Edesa Biotech Inc. (NASDAQ: EDSA)
$1.6500
-0.0763 ( -7.30% ) 5.3K
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Market Data
Open
$1.6500
Previous close
$1.7263
Volume
5.3K
Market cap
$6.17M
Day range
$1.7500 - $2.0500
52 week range
$1.5500 - $5.9900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 104 | Apr 05, 2024 |
def | Proxies and info statements | 3 | Apr 05, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
10-q | Quarterly Reports | 63 | Feb 09, 2024 |
8-k | 8K-related | 18 | Feb 09, 2024 |
4 | Insider transactions | 2 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 12, 2024 |
8-k | 8K-related | 16 | Dec 15, 2023 |